Rivastigmine in Parkinson's disease dementia: profile report
- PMID: 17362052
- DOI: 10.2165/00002512-200724030-00006
Rivastigmine in Parkinson's disease dementia: profile report
Similar articles
-
Rivastigmine for dementia associated with Parkinson's disease.N Engl J Med. 2005 Mar 31;352(13):1387; author reply 1387. doi: 10.1056/NEJM200503313521325. N Engl J Med. 2005. PMID: 15800242 No abstract available.
-
Rivastigmine in Parkinson's disease dementia.Expert Opin Drug Metab Toxicol. 2009 Aug;5(8):941-55. doi: 10.1517/17425250903105420. Expert Opin Drug Metab Toxicol. 2009. PMID: 19619073 Review.
-
Efficacy of rivastigmine on executive function in patients with Parkinson's disease dementia.CNS Neurosci Ther. 2010 Dec;16(6):330-6. doi: 10.1111/j.1755-5949.2010.00182.x. Epub 2010 Oct 15. CNS Neurosci Ther. 2010. PMID: 20950329 Free PMC article. Clinical Trial.
-
Rivastigmine for dementia associated with Parkinson's disease.Curr Neurol Neurosci Rep. 2005 Jul;5(4):263-5. doi: 10.1007/s11910-005-0070-8. Curr Neurol Neurosci Rep. 2005. PMID: 15987609 Clinical Trial. No abstract available.
-
[Lewy body dementia and Parkinson disease dementia].Presse Med. 2007 Oct;36(10 Pt 2):1485-90. doi: 10.1016/j.lpm.2007.04.025. Epub 2007 Jun 14. Presse Med. 2007. PMID: 17572053 Review. French.
Cited by
-
Treatment of Alzheimer's Disease: Current Management and Experimental Therapeutics.Curr Transl Geriatr Exp Gerontol Rep. 2013 Sep;2(3):174-181. doi: 10.1007/s13670-013-0056-3. Curr Transl Geriatr Exp Gerontol Rep. 2013. PMID: 24093080 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical